We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
-0.59%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.52B
AUM Growth
+$35M
(+2.3%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
3.18%
Top 10 Holdings %
Top 10 Hldgs %
38.17%
Holding
1,046
New
109
Increased
375
Reduced
212
Closed
65
Avg Time Held
2.5
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$5.91M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.08M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$4.06M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$3.36M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$5.93M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$2.6M |
| 3 |
iShares Core Dividend Growth ETF
DGRO
|
+$1.94M |
| 4 |
FMC
FMC
|
+$1.9M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$895K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 68.1% |
| 2 | Technology | 7.07% |
| 3 | Financials | 5.32% |
| 4 | Healthcare | 4.52% |
| 5 | Industrials | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Golub Capital BDC
GBDC
$3.15B
| $16K | ﹤0.01% |
+1,002
| New | +$15.7K |
2021 Q3
0 quarters
|
|
727
Genuine Parts
GPC
$18.5B
| $16K | ﹤0.01% |
131
+39
| +42% | +$4.86K |
2021 Q2
1 quarter
|
|
728
Invesco
IVZ
$12.5B
| $16K | ﹤0.01% |
657
+241
| +58% | +$6.03K |
2021 Q2
1 quarter
|
|
729
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$41.2M
| $16K | ﹤0.01% |
+266
| New | +$15.6K |
2021 Q3
0 quarters
|
|
730
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.45B
| $16K | ﹤0.01% |
404
| – | – |
2018 Q4
11 quarters
|
|
731
Roku
ROKU
$23B
| $16K | ﹤0.01% |
50
| – | – |
2020 Q4
3 quarters
|
|
732
Teradyne
TER
$50.8B
| $16K | ﹤0.01% |
148
+73
| +97% | +$8.87K |
2020 Q3
4 quarters
|
|
733
AstraZeneca
AZN
$257B
| $15K | ﹤0.01% |
129
-21
| -14% | -$2.44K |
2020 Q4
3 quarters
|
|
734
Franklin Templeton
BEN
$15.7B
| $15K | ﹤0.01% |
512
+184
| +56% | +$5.74K |
2021 Q2
1 quarter
|
|
735
Broadridge
BR
$19.8B
| $15K | ﹤0.01% |
88
| – | – |
2018 Q4
11 quarters
|
|
736
Dell
DELL
$287B
| $15K | ﹤0.01% |
282
| – | – |
2018 Q1
14 quarters
|
|
737
Amdocs
DOX
$6.27B
| $15K | ﹤0.01% |
204
| – | – |
2019 Q1
10 quarters
|
|
738
Innovator Emerging Markets Power Buffer ETF January
EJAN
$141M
| $15K | ﹤0.01% |
503
| – | – |
2021 Q1
2 quarters
|
|
739
Fidelity National Financial
FNF
$10.7B
| $15K | ﹤0.01% |
344
+308
| +856% | +$13.7K |
2020 Q4
3 quarters
|
|
740
GSK
GSK
$99.2B
| $15K | ﹤0.01% |
+324
| New | +$16.3K |
2021 Q3
0 quarters
|
|
741
Marsh
MRSH
$89.9B
| $15K | ﹤0.01% |
101
+1
| +1% | +$151 |
2021 Q1
2 quarters
|
|
742
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $15K | ﹤0.01% |
+106
| New | +$15.1K |
2021 Q3
0 quarters
|
|
743
BCE
BCE
$19B
| $14K | ﹤0.01% |
280
+223
| +391% | +$11.3K |
2020 Q4
3 quarters
|
|
744
Cognizant
CTSH
$29.7B
| $14K | ﹤0.01% |
+183
| New | +$13.5K |
2021 Q3
0 quarters
|
|
745
Consolidated Edison
ED
$41.5B
| $14K | ﹤0.01% |
189
+2
| +1% | +$149 |
2021 Q1
2 quarters
|
|
746
Edison International
EIX
$21.5B
| $14K | ﹤0.01% |
253
+3
| +1% | +$172 |
2020 Q2
5 quarters
|
|
747
Lazard
LAZ
$3.52B
| $14K | ﹤0.01% |
300
-40
| -12% | -$1.87K |
2021 Q1
2 quarters
|
|
748
Omeros
OMER
$1.17B
| $14K | ﹤0.01% |
1,000
| – | – |
2021 Q1
2 quarters
|
|
749
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$177M
| $14K | ﹤0.01% |
450
+100
| +29% | +$3.31K |
2021 Q2
1 quarter
|
|
750
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11.2B
| $14K | ﹤0.01% |
456
-73
| -14% | -$2.28K |
2018 Q4
11 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2021 Portfolio in Review
As of Q3 2021, Capital Analysts LLC held 1,046 positions worth $1.52B, up 2.3% from $1.49B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Analysts LLC deployed $48.4M of net new capital in Q3 2021, opening 109 new positions and adding to 375 existing holdings. Its largest new stake was Ally Financial: 114,350 shares worth $5.84M.
By sector, the portfolio is most concentrated in Miscellaneous at 68% of assets, up from 68% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Canadian Pacific Kansas City, an estimated $5.93M trimmed.
- Capital Analysts LLC's largest Q3 2021 buy was Ally Financial: 114,350 shares worth $5.84M.
- Capital Analysts LLC added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $4.08M increase.
- Capital Analysts LLC's biggest Q3 2021 reduction was Canadian Pacific Kansas City, cutting an estimated $5.93M.
- Capital Analysts LLC fully exited FMC in Q3 2021, selling an estimated $1.9M.
- Capital Analysts LLC's ten largest holdings make up 38% of its $1.52B portfolio in Q3 2021.
- Capital Analysts LLC opened 109 new positions and closed 65 in Q3 2021.
- Capital Analysts LLC's portfolio value rose 2.3% quarter-over-quarter to $1.52B.
Based on Capital Analysts LLC's 13F filing for Q3 2021, filed 4 Nov 2021.